The BCL2-938 C>A promoter polymorphism is associated with risk group classification in children with acute

Annette Künkele1, Anja Grosse-Lordemann, Alexander Schramm

  • 1Department of Pediatric Hematology-Oncology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany. annette.kuenkele@uk-essen.de.

BMC Cancer
|October 4, 2013
PubMed
Abstract